Davis Polk advised Gyroscope Therapeutics Limited on the deal.Gyroscope Therapeutics Limited executed its $148 million private placement of Series C preferred shares. The financing was led…
Davis Polk advised Gyroscope Therapeutics Limited on the deal.Gyroscope Therapeutics Limited executed its $148 million private placement of Series C preferred shares. The financing was led…
You must be a Standard 1 Year member to access this content.
…
You must be a Standard 1 Year member to access this content.